Power Finance Corporation's board has approved an in-principle merger with subsidiary REC Ltd, following the government's Budget push to restructure public sector NBFCs
The move follows Securities and Exchange Board of India operationalising a unified digital workflow in January 2026
Group would establish its largest integrated manufacturing facility for automobiles and tractors around the city
Airtel has sought parity with Vodafone Idea on AGR dues reassessment and says it has written multiple times to the DoT, while outlining its plans on data centres, ARPU growth and 5G strategy
Garrison also said that the India business has doubled every five years and, in the short term, the growth could be even faster
CEO said buying for investment had peaked in the past one year
The Gautam Adani-led Adani Group plans to invest ₹70,000 crore across energy, logistics and airport infrastructure in Vidarbha, reinforcing its long-term commitment to Maharashtra's industrial and eco
Mitsubishi Electric India has begun operations at its new air conditioner and compressor manufacturing facility in Chennai, marking a Rs 2,100 crore investment
PFC's board has approved an in-principle merger with REC after the Budget 2026 proposal to restructure the two public-sector NBFCs. The merger details are yet to be finalised
JM Financial's Q3 FY26 profit jumps 50% to ₹313 crore, led by strong corporate advisory, capital markets execution and robust private markets performance
The announcement was made at Advantage Vidarbha, a three-day flagship event positioning the region as an emerging industrial growth hub on India's manufacturing map
The PSU is aggressively expanding into the exploration and development of critical minerals to support the country's green energy transition and reduce dependence on imports
The approval by the US Food & Drug Administration (USFDA) is for the Abbreviated New Drug Application (ANDA) of Carbidopa, Levodopa and Entacapone tablets
Under the MoA, the car major will automate and maintain these driving test tracks for a period of three years from the date of commissioning
The US Food and Drugs Administration's (USFDA) grants orphan status to support development of medicines for the treatment of rare diseases that affect fewer than 2 lakh people in the US
Alembic Pharmaceuticals said it will miss the first wave of global generic semaglutide launches but is exploring partnerships for a faster entry into the Indian market
The EU's ban on importing products produced from Russian crude is aimed at curbing oil revenues Moscow uses to fund the Ukraine war
In a video-interview with Sohini Das, Surendran Chemmenkotil, Managing Director of Metropolis Healthcare, speaks about the company's FY27 network expansion strategy
New plug-ins let Claude automate legal, sales and analytics tasks, raising fears of AI-led disruption to traditional software and IT services
IOC's revenue from operations rose 7.7 per cent to Rs 2.36 lakh crore in the quarter ended December 2025